Tuberous Sclerosis: Multimedia

References

1. Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology. Oct 22 1999;53(7):1384-90. [Medline].

2. Jozwiak J. Hamartin and tuberin: working together for tumour suppression. Int J Cancer. Jan 1 2006;118(1):1-5. [Medline].

3. Jozwiak J, Jozwiak S. Giant cells: contradiction to two-hit model of tuber formation?. Cell Mol Neurobiol. Aug 2005;25(5):795-805. [Medline].

4. Jozwiak J, Wlodarski P. Hamartin and tuberin modulate gene transcription via beta-catenin. J Neurooncol. Sep 2006;79(3):229-34. [Medline].

5. Jozwiak J, Grajkowska W, Kotulska K, Jozwiak S, Zalewski W, Zajaczkowska A. Brain tumor formation in tuberous sclerosis depends on Erk activation. Neuromolecular Med. 2007;9(2):117-27. [Medline].

6. Jozwiak J, Jozwiak S, Wlodarski P. Possible mechanisms of disease development in tuberous sclerosis. Lancet Oncol. Jan 2008;9(1):73-9. [Medline].

7. Jozwiak J, Sahin M, Jozwiak S, et al. Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling. Int J Cardiol. Feb 6 2009;132(1):145-7. [Medline].

8. Rok P, Kasprzyk-Obara J, Domanska-Pakiela D, Jozwiak S. Clinical symptoms of tuberous sclerosis complex in patients with an identical TSC2 mutation. Med Sci Monit. May 2005;11(5):CR230-234. [Medline].

9. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. Dec 1998;13(12):624-8. [Medline].

10. Jozwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol. Oct 2000;15(10):652-9. [Medline].

11. Schwartz RA, Fernandez G, Kotulska K, Jozwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol. Aug 2007;57(2):189-202. [Medline].

12. Jozwiak S, Domanska-Pakiela D, Kwiatkowski DJ, Kotulska K. Multiple cardiac rhabdomyomas as a sole symptom of tuberous sclerosis complex: case report with molecular confirmation. J Child Neurol. Dec 2005;20(12):988-9. [Medline].

13. Sparling JD, Hong CH, Brahim JS, Moss J, Darling TN. Oral findings in 58 adults with tuberous sclerosis complex. J Am Acad Dermatol. May 2007;56(5):786-90. [Medline].

14. Hyman MH, Whittemore VH. National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol. May 2000;57(5):662-5. [Medline].

15. Jozwiak S, Schwartz RA, Janniger CK, Michalowicz R, Chmielik J. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. Dec 1998;37(12):911-7. [Medline].

16. Rama Rao GR, Krishna Rao PV, Gopal KV, Kumar YH, Ramachandra BV. Forehead plaque: a cutaneous marker of CNS involvement in tuberous sclerosis. Indian J Dermatol Venereol Leprol. Jan-Feb 2008;74(1):28-31. [Medline].

17. Moudouni SM, Tligui M, Sibony M, Doublet JD, Haab F, Gattegno B. Malignant epithelioid renal angiomyolipoma involving the inferior vena cava in a patient with tuberous sclerosis. Urol Int. 2008;80(1):102-4; discussion 104. [Medline].

18. Hasselblatt M, Jozwiak J, Mayer K, et al. Hypothalamic papillary tumor in a patient with tuberous sclerosis. Am J Surg Pathol. Oct 2008;32(10):1578-80. [Medline].

19. Huggins RH, Janusz CA, Schwartz RA. Vitiligo: a sign of systemic disease. Indian J Dermatol Venereol Leprol. Jan-Feb 2006;72(1):68-71. [Medline].

20. Jurkiewicz E, Jozwiak S, Bekiesinska-Figatowska M, Pakula-Kosciesza I, Walecki J. Cyst-like cortical tubers in patients with tuberous sclerosis complex: MR imaging with the FLAIR sequence. Pediatr Radiol. Jun 2006;36(6):498-501. [Medline].

21. Jozwiak J, Jozwiak S, Oldak M. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Med Res Rev. Mar 2006;26(2):160-80. [Medline].

22. Paghdal KV, Schwartz RA. Sirolimus (rapamycin): from the soil of Easter Island to a bright future. J Am Acad Dermatol. Dec 2007;57(6):1046-50. [Medline].

23. Davies DM, Johnson SR, Tattersfield AE, Kingswood JC, Cox JA, McCartney DL. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med. Jan 10 2008;358(2):200-3. [Medline].

24. Matsuyama K, Ohsawa I, Ogawa T. Do children with tuberous sclerosis complex have superior musical skill? - A unique tendency of musical responsiveness in children with TSC. Med Sci Monit. Mar 27 2007;13(4):CR156-164. [Medline].

25. Brodie MJ. Lamotrigine--an update. Can J Neurol Sci. Nov 1996;23(4):S6-9. [Medline].

26. Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med. Jan 18 1996;334(3):168-75. [Medline].

27. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. Aug 23 2008;372(9639):657-68. [Medline].

28. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. Jan 2001;68(1):64-80. [Medline].

29. de Vries PJ, Watson P. Attention deficits in tuberous sclerosis complex (TSC): rethinking the pathways to the endstate. J Intellect Disabil Res. Dec 19 2007;[Medline].

30. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med. Jun 13 1996;334(24):1583-90. [Medline].

31. Franz DN. Diagnosis and management of tuberous sclerosis complex. Semin Pediatr Neurol. Dec 1998;5(4):253-68. [Medline].

32. Haslam RH. Nonfebrile seizures. Pediatr Rev. Feb 1997;18(2):39-49. [Medline].

33. Hurst JS, Wilcoski S. Recognizing an index case of tuberous sclerosis. Am Fam Physician. Feb 1 2000;61(3):703-8, 710. [Medline].

34. Husain AM, Foley CM, Legido A, et al. Tuberous sclerosis complex and epilepsy: prognostic significance of electroencephalography and magnetic resonance imaging. J Child Neurol. Feb 2000;15(2):81-3. [Medline].

35. Jozwiak J, Galus R. Molecular implications of skin lesions in tuberous sclerosis. Am J Dermatopathol. Jun 2008;30(3):256-61. [Medline].

36. Jozwiak J, Kotulska K, Lojek M, et al. Fibroblasts from normal skin of a tuberous sclerosis patient show upregulation of mTOR pathway. Am J Dermatopathol. Feb 2009;31(1):68-70. [Medline].

37. Jozwiak J, Sahin M, Jozwiak S, et al. Cardiac rhabdomyoma in tuberous sclerosis: Hyperactive Erk signaling. Int J Cardiol. Nov 23 2007;[Medline].

38. Jozwiak S, Domanska-Pakiela D, Kotulska K, Kaczorowska M. Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex. Epilepsia. Aug 2007;48(8):1632; author reply 1632-4. [Medline].

39. Jozwiak S, Kotulska K, Kasprzyk-Obara J, Domanska-Pakiela D, Tomyn-Drabik M, Roberts P. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex. Pediatrics. Oct 2006;118(4):e1146-51. [Medline].

40. Jurkiewicz E, Jozwiak S. Giant intracranial aneurysm in a 9-year-old boy with tuberous sclerosis. Pediatr Radiol. May 2006;36(5):463. [Medline].

41. Korf BR. Neurocutaneous syndromes: neurofibromatosis 1, neurofibromatosis 2, and tuberous sclerosis. Curr Opin Neurol. Apr 1997;10(2):131-6. [Medline].

42. Krymskaya VP, Goncharova EA. PI3K/mTORC1 activation in hamartoma syndromes: Therapeutic prospects. Cell Cycle. Feb 6 2009;8(3):[Medline].

43. Martin N, Debussche C, De Broucker T, et al. Gadolinium-DTPA enhanced MR imaging in tuberous sclerosis. Neuroradiology. 1990;31(6):492-7. [Medline].

44. Miller SP, Tasch T, Sylvain M, et al. Tuberous sclerosis complex and neonatal seizures. J Child Neurol. Dec 1998;13(12):619-23. [Medline].

45. Monaghan HP, Krafchik BR, MacGregor DL, Fitz CR. Tuberous sclerosis complex in children. Am J Dis Child. Oct 1981;135(10):912-7. [Medline].

46. Morse RP. Tuberous sclerosis. Arch Neurol. Sep 1998;55(9):1257-8. [Medline].

47. Nakase Y, Fukuda K, Chikashige Y, et al. A defect in protein farnesylation suppresses a loss of Schizosaccharomyces pombe tsc2+, a homolog of the human gene predisposing to tuberous sclerosis complex. Genetics. Jun 2006;173(2):569-78. [Medline]. [Full Text].

48. O'Hagan AR, Ellsworth R, Secic M, Rothner AD, Brouhard BH. Renal manifestations of tuberous sclerosis complex. Clin Pediatr (Phila). Oct 1996;35(10):483-9. [Medline].

49. Roach ES, Williams DP, Laster DW. Magnetic resonance imaging in tuberous sclerosis. Arch Neurol. Mar 1987;44(3):301-3. [Medline].

50. Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc. Aug 1991;66(8):792-6. [Medline].

51. Stefansson K. Tuberous sclerosis. Mayo Clin Proc. Aug 1991;66(8):868-72. [Medline].

52. Wlodarski PK, Maksym R, Oldak M, Jozwiak S, Wojcik A, Jozwiak J. Tuberin-heterozygous cell line TSC2ang1 as a model for tuberous sclerosis-associated skin lesions. Int J Mol Med. Feb 2008;21(2):245-50. [Medline].

Further Reading

Keywords

tuberous sclerosis, tuberous sclerosis complex, TSC, Bourneville disease, neurocutaneous disease, mental retardation, epilepsy, facial angiofibromas, cortical tubers, subependymal nodules, SEN, subependymal giant cell astrocytomas, SEGA, hypomelanotic lesions, Fitzpatrick patches, ash-leaf spots, cardiac rhabdomyomas, renal angiomyolipomas, hamartomas, confetti lesions, shagreen patches, fibrous plaques, periungual fibromas, renal cysts, angiomyolipomas, spontaneous pneumothorax, cor pulmonale, phalangeal cysts, status epilepticus, bronchopneumonia

autism, pervasive developmental disorder, PDD, outflow obstruction, cardiomyopathy, arrhythmia, polycystic kidney disease, PKD, lymphangioleiomyomatosis, LAM, pulmonary cysts, phalangeal cysts, sclerotic lesions, hydrocephalus, sleep disorder, hyperactivity, schizophrenia, cafe au lait spots

Contributor Information and Disclosures

Author

Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

Coauthor(s)

Sergiusz Jozwiak, MD, PhD, Head, Professor, Department of Child Neurology, The Children's Memorial Health Institute of Warsaw, Poland
Sergiusz Jozwiak, MD, PhD is a member of the following medical societies: Sigma Xi
Disclosure: Nothing to disclose.

Robert Pedersen, MD, Chief of Child Neurology, Assistant Professor, Departments of Pediatrics and Neurology, Tripler Army Medical Center
Robert Pedersen, MD is a member of the following medical societies: American Academy of Pediatrics and Child Neurology Society
Disclosure: Nothing to disclose.

Medical Editor

Erawati V Bawle, MD, FAAP, FACMG, Division of Genetic and Metabolic Disorders, Children's Hospital of Michigan; Professor (Clinician-Educator), Department of Pediatrics, Wayne State University School of Medicine
Erawati V Bawle, MD, FAAP, FACMG is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics, American Medical Association, and American Society of Human Genetics
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Leonard G Feld, MD, PhD, MMM, FAAP, Sara H Bissell and Howard C Bissell Endowed Chair in Pediatrics, Chief Medical Officer, Levine Children's Hospital, Carolinas Medical Center
Leonard G Feld, MD, PhD, MMM, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Physician Executives, American Society of Nephrology, American Society of Pediatric Nephrology, International Society of Nephrology, and Juvenile Diabetes Foundation International
Disclosure: Nothing to disclose.

CME Editor

Paul D Petry, DO, FACOP, FAAP, Consulting Staff, Freeman Pediatric Care, Freeman Health System
Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association
Disclosure: Nothing to disclose.

Chief Editor

Bruce Buehler, MD, Professor, Department of Pediatrics, Pathology and Microbiology, Executive Director, Hattie B Munroe Center for Human Genetics and Rehabilitation, University of Nebraska Medical Center
Bruce Buehler, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Pediatrics, American Association on Mental Retardation, American College of Medical Genetics, American College of Physician Executives, American Medical Association, and Nebraska Medical Association
Disclosure: Nothing to disclose.